CVR Medical Corp. (CRRVF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2022 | - USD | -100.0% |
| 2021 | 679.37 Thousand USD | 10.45% |
| 2020 | 615.07 Thousand USD | 332.7% |
| 2019 | 142.14 Thousand USD | 385.77% |
| 2018 | -49.74 Thousand USD | 89.27% |
| 2017 | -463.43 Thousand CAD | -374.66% |
| 2016 | -97.63 Thousand CAD | -1350.3% |
| 2015 | -6732.05 CAD | -774.16% |
| 2014 | -770.12 CAD | -21.66% |
| 2013 | -633.00 CAD | 99.41% |
| 2012 | -107.58 Thousand CAD | -788.39% |
| 2011 | -12.11 Thousand CAD | -79.86% |
| 2010 | -6732.92 CAD | 70.4% |
| 2009 | -22.74 Thousand CAD | -1228.94% |
| 2008 | -1711.59 CAD | 97.69% |
| 2007 | -74 Thousand CAD | 36.54% |
| 2006 | -116.61 Thousand CAD | -48.86% |
| 2005 | -78.33 Thousand CAD | -1061.63% |
| 2004 | -6743.81 CAD | 76.34% |
| 2003 | -28.5 Thousand CAD | 69.36% |
| 2002 | -93.05 Thousand CAD | 39.31% |
| 2001 | -153.32 Thousand CAD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q1 | - USD | 0.0% |
| 2023 Q2 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2022 FY | - USD | -100.0% |
| 2022 Q2 | 803.45 Thousand USD | 1.7% |
| 2022 Q3 | 868.77 Thousand USD | 8.13% |
| 2022 Q4 | - USD | -100.0% |
| 2022 Q1 | 790.05 Thousand USD | 16.29% |
| 2021 Q4 | 679.37 Thousand USD | -11.22% |
| 2021 Q2 | 716.36 Thousand USD | 8.02% |
| 2021 Q1 | 663.17 Thousand USD | 7.82% |
| 2021 Q3 | 765.21 Thousand USD | 6.82% |
| 2021 FY | 679.37 Thousand USD | 10.45% |
| 2020 Q3 | 319.29 Thousand USD | 41.78% |
| 2020 Q1 | 190.98 Thousand USD | 34.35% |
| 2020 Q4 | 615.07 Thousand USD | 92.64% |
| 2020 Q2 | 225.19 Thousand USD | 17.92% |
| 2020 FY | 615.07 Thousand USD | 332.7% |
| 2019 Q3 | 23.73 Thousand USD | 12.95% |
| 2019 Q4 | 142.14 Thousand USD | 499.0% |
| 2019 FY | 142.14 Thousand USD | 385.77% |
| 2019 Q1 | -555.16 Thousand USD | -1016.09% |
| 2019 Q2 | 21.01 Thousand USD | 103.78% |
| 2018 Q4 | -49.74 Thousand USD | 15.2% |
| 2018 Q1 | -93.85 Thousand CAD | 79.75% |
| 2018 Q2 | -60.99 Thousand CAD | 35.01% |
| 2018 Q3 | -58.66 Thousand CAD | 3.83% |
| 2018 FY | -49.74 Thousand USD | 89.27% |
| 2017 Q2 | -1.85 Million CAD | -315.03% |
| 2017 Q3 | -1.89 Million CAD | -1.8% |
| 2017 Q1 | -447.5 Thousand CAD | -358.35% |
| 2017 FY | -463.43 Thousand CAD | -374.66% |
| 2017 Q4 | -463.43 Thousand CAD | 75.49% |
| 2016 Q3 | -356.96 Thousand CAD | -9974.83% |
| 2016 FY | -97.63 Thousand CAD | -1350.3% |
| 2016 Q1 | -560.85 CAD | 91.67% |
| 2016 Q2 | -3543.11 CAD | -531.74% |
| 2016 Q4 | -97.63 Thousand CAD | 72.65% |
| 2015 Q2 | -2145.31 CAD | 48.29% |
| 2015 Q1 | -4148.92 CAD | -438.74% |
| 2015 FY | -6732.05 CAD | -774.16% |
| 2015 Q4 | -6732.05 CAD | -298.32% |
| 2015 Q3 | -1690.13 CAD | 21.22% |
| 2014 FY | -770.12 CAD | -21.66% |
| 2014 Q2 | -5343.57 CAD | -126.66% |
| 2014 Q1 | -2357.56 CAD | -272.44% |
| 2014 Q3 | -1283.84 CAD | 75.97% |
| 2014 Q4 | -770.12 CAD | 40.01% |
| 2013 Q4 | -633.00 CAD | 94.95% |
| 2013 FY | -633.00 CAD | 99.41% |
| 2013 Q3 | -12.54 Thousand CAD | 64.42% |
| 2013 Q2 | -35.26 Thousand CAD | 34.37% |
| 2013 Q1 | -53.73 Thousand CAD | 50.06% |
| 2012 Q3 | -163.9 Thousand CAD | -19793.77% |
| 2012 Q4 | -107.58 Thousand CAD | 34.36% |
| 2012 Q1 | -3010.89 CAD | 75.14% |
| 2012 FY | -107.58 Thousand CAD | -788.39% |
| 2012 Q2 | -823.91 CAD | 72.64% |
| 2011 Q3 | -16.12 Thousand CAD | -57.05% |
| 2011 Q4 | -12.11 Thousand CAD | 24.88% |
| 2011 FY | -12.11 Thousand CAD | -79.86% |
| 2011 Q1 | -18.39 Thousand CAD | -173.14% |
| 2011 Q2 | -10.26 Thousand CAD | 44.19% |
| 2010 Q4 | -6732.92 CAD | 0.0% |
| 2010 FY | -6732.92 CAD | 70.4% |
| 2009 FY | -22.74 Thousand CAD | -1228.94% |
| 2008 Q2 | -4728.83 CAD | 76.89% |
| 2008 FY | -1711.59 CAD | 97.69% |
| 2008 Q4 | -1711.59 CAD | 64.45% |
| 2008 Q1 | -20.46 Thousand CAD | 72.35% |
| 2008 Q3 | -4814.85 CAD | -1.82% |
| 2007 Q4 | -74 Thousand CAD | 79.31% |
| 2007 FY | -74 Thousand CAD | 36.54% |
| 2007 Q1 | -753.23 Thousand CAD | -545.93% |
| 2007 Q2 | -828.55 Thousand CAD | -10.0% |
| 2007 Q3 | -357.72 Thousand CAD | 56.83% |
| 2006 Q2 | -148.62 Thousand CAD | 72.55% |
| 2006 Q4 | -116.61 Thousand CAD | 73.24% |
| 2006 FY | -116.61 Thousand CAD | -48.86% |
| 2006 Q3 | -435.8 Thousand CAD | -193.24% |
| 2006 Q1 | -541.45 Thousand CAD | -591.17% |
| 2005 Q3 | -203.78 Thousand CAD | -313.48% |
| 2005 Q4 | -78.33 Thousand CAD | 61.56% |
| 2005 Q2 | -49.28 Thousand CAD | -1640.7% |
| 2005 Q1 | -2831.28 CAD | 58.02% |
| 2005 FY | -78.33 Thousand CAD | -1061.63% |
| 2004 Q2 | -60.91 Thousand CAD | -647.34% |
| 2004 Q3 | -42.74 Thousand CAD | 29.82% |
| 2004 Q4 | -6743.81 CAD | 84.22% |
| 2004 FY | -6743.81 CAD | 76.34% |
| 2004 Q1 | -8150.42 CAD | 71.41% |
| 2003 Q3 | -5821.01 CAD | 78.65% |
| 2003 Q4 | -28.5 Thousand CAD | -389.76% |
| 2003 FY | -28.5 Thousand CAD | 69.36% |
| 2003 Q1 | -56.93 Thousand CAD | 38.81% |
| 2003 Q2 | -27.26 Thousand CAD | 52.11% |
| 2002 Q2 | -492.58 CAD | 96.69% |
| 2002 FY | -93.05 Thousand CAD | 39.31% |
| 2002 Q1 | -14.88 Thousand CAD | 0.0% |
| 2002 Q4 | -93.05 Thousand CAD | -299.88% |
| 2002 Q3 | -23.27 Thousand CAD | -4624.29% |
| 2001 FY | -153.32 Thousand CAD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| BioElectronics Corporation | 14.82 Million USD | 100.0% |
| Medical Supply International USA, Inc. | 216.6 Thousand USD | 100.0% |
| Polarean Imaging plc | -5.94 Million USD | 100.0% |
| Avitar, Inc. | 5.17 Million USD | 100.0% |
| IR-Med Inc. | -606 Thousand USD | 100.0% |
| AVITA Medical, Inc. | -26.23 Million USD | 100.0% |
| Manhattan Scientifics, Inc. | -7000.00 USD | 100.0% |
| Össur hf. | 395.08 Million USD | 100.0% |
| Zecotek Photonics Inc. | 2.76 Million USD | 100.0% |
| QHSLab, Inc. | 1.72 Million USD | 100.0% |
| Wellstar International, Inc. | 51.36 Million USD | 100.0% |
| Össur hf. | 395.08 Million USD | 100.0% |
| Bionovate Technologies Corp | - USD | NaN% |
| EKF Diagnostics Holdings plc | -4.61 Million USD | 100.0% |
| Escalon Medical Corp. | 315.68 Thousand USD | 100.0% |
| Aurora Spine Corporation | 1.9 Million USD | 100.0% |
| BrainsWay Ltd. | -10.32 Million USD | 100.0% |
| Lattice Biologics Ltd. | - USD | NaN% |
| NewCardio, Inc. | 2.41 Million USD | 100.0% |
| Hamilton Thorne Ltd. | 18.12 Million USD | 100.0% |
| Vivos Inc. | -1.59 Million USD | 100.0% |
| MicroPort Scientific Corporation | 673.58 Million USD | 100.0% |
| Kelyniam Global, Inc. | 487.33 Thousand USD | 100.0% |
| REMSleep Holdings, Inc. | -540.98 Thousand USD | 100.0% |
| CYduct Diagnostics, Inc. | 640.19 Thousand USD | 100.0% |
| Nanomix Corporation | 11.38 Million USD | 100.0% |
| Theraclion SA | -5.86 Million EUR | 100.0% |
| Lifeline Biotechnologies, Inc. | - USD | NaN% |
| Wellness Center USA, Inc. | 3.98 Million USD | 100.0% |
| Positron Corporation | 1.68 Million USD | 100.0% |
| Rafina Innovations Inc. | - USD | NaN% |
| Electromedical Technologies, Inc. | 1.61 Million USD | 100.0% |
| Lombard Medical, Inc. | 11.49 Million USD | 100.0% |
| ALR Technologies Inc. | 19.14 Million USD | 100.0% |
| Stratec SE | 119.12 Million USD | 100.0% |
| Vycor Medical, Inc. | 1.05 Million USD | 100.0% |
| Heart Tronics, Inc. | 54.99 Thousand USD | 100.0% |
| Nu-Med Plus, Inc. | 93.19 Thousand USD | 100.0% |
| Perimeter Medical Imaging AI, Inc. | -13.78 Million USD | 100.0% |
| SANUWAVE Health, Inc. | 30.14 Million USD | 100.0% |
| VMS Rehab Systems, Inc. | 133.52 USD | 100.0% |
| Guided Therapeutics, Inc. | 1.46 Million USD | 100.0% |
| Ingen Technologies, Inc. | 630.91 Thousand USD | 100.0% |
| Odyssey Group International, Inc. | 2.1 Million USD | 100.0% |
| United American Healthcare Corporation | -9.32 Million USD | 100.0% |
| ECGI Holdings, Inc. | 3.17 Million USD | 100.0% |
| Capital Group Holdings, Inc. | -3508.00 USD | 100.0% |
| ADM Tronics Unlimited, Inc. | 262.61 Thousand USD | 100.0% |
| Urologix, Inc. | 4.61 Million USD | 100.0% |
| Rapid Therapeutic Science Laboratories, Inc. | 4.2 Million USD | 100.0% |
| Nexeon MedSystems Inc. | 3.33 Million USD | 100.0% |
| SS Innovations International, Inc. | 1.18 Million USD | 100.0% |
| Qualis Innovations, Inc. | 6671.00 USD | 100.0% |
| Smith & Nephew plc | 2.77 Billion USD | 100.0% |
| NIOX Group Plc | -23.93 Million USD | 100.0% |
| Fuse Medical, Inc. | 1.75 Million USD | 100.0% |
| Broncus Holding Corporation | -81.42 Million USD | 100.0% |
| Brain Scientific Inc. | 2.11 Million USD | 100.0% |
| Pressure BioSciences, Inc. | 22.67 Million USD | 100.0% |
| Health Logic Interactive Inc. | 39.55 Thousand USD | 100.0% |